Capstone Asset Management’s Elevance Health ELV Stock Holding History

Capstone Asset Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$6.25M	Buy	33,232 +1,440	+5%	+$259K	0.17%	141
2017 Q1	$5.26M	Buy	31,792 +951	+3%	+$151K	0.15%	164
2016 Q4	$4.43M	Sell	30,841 -434	-1%	-$58.1K	0.13%	193
2016 Q3	$3.92M	Buy	31,275 +667	+2%	+$86.1K	0.11%	206
2016 Q2	$4.02M	Sell	30,608 -1,052	-3%	-$144K	0.12%	196
2016 Q1	$4.4M	Sell	31,660 -1,870	-6%	-$250K	0.13%	200
2015 Q4	$4.67M	Buy	33,530 +4,649	+16%	+$640K	0.13%	183
2015 Q3	$4.04M	Buy	28,881 +397	+1%	+$59.7K	0.13%	197
2015 Q2	$4.67M	Buy	28,484 +639	+2%	+$102K	0.13%	190
2015 Q1	$4.3M	Buy	27,845 +1,210	+5%	+$172K	0.12%	207
2014 Q4	$3.35M	Sell	26,635 -740	-3%	-$91.4K	0.1%	264
2014 Q3	$3.27M	Buy	27,375 +1,040	+4%	+$119K	0.11%	224
2014 Q2	$2.83M	Sell	26,335 -4,320	-14%	-$445K	0.09%	263
2014 Q1	$3.05M	Sell	30,655 -6,340	-17%	-$573K	0.09%	250
2013 Q4	$3.42M	Sell	36,995 -17,414	-32%	-$1.55M	0.1%	237
2013 Q3	$4.55M	Sell	54,409 -894	-2%	-$76.6K	0.11%	206
2013 Q2	$4.53M	Buy	+55,303	New	+$4.14M	0.12%	185

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capstone Asset Management's ELV Position: Q2 2017 in Review

Capstone Asset Management increased its Elevance Health (ELV) stake by 4.5% in Q2 2017, buying an estimated $259K and bringing the position to 33,232 shares worth $6.25M. The position accounts for 0.17% of the portfolio, ranked #141.

Capstone Asset Management first reported a position in ELV in Q2 2013 and has held it in 17 quarters since. 851 funds tracked by Wall St. Rank hold ELV as of Q2 2017.

Capstone Asset Management held 33,232 shares of Elevance Health worth $6.25M as of Q2 2017.
Capstone Asset Management bought 1,440 Elevance Health shares in Q2 2017, an estimated $259K.
Elevance Health made up 0.17% of Capstone Asset Management's portfolio in Q2 2017, its #141 holding.
Capstone Asset Management first reported a position in Elevance Health in Q2 2013 and has held it in 17 quarters since.
851 funds tracked by Wall St. Rank held Elevance Health as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.